NCT01602289View on ClinicalTrials.gov

A Study of LY2875358 in Japanese Participants With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Solid TumorsLymphomaCarcinoma, Non-Small-Cell Lung
Interventions
BIOLOGICAL

LY2875358

Administered IV

DRUG

Erlotinib

Administered orally

DRUG

Gefitinib

Administered orally

Trial Locations (1)

277-8577

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Chiba

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01602289 - A Study of LY2875358 in Japanese Participants With Advanced Cancer | Biotech Hunter | Biotech Hunter